Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Abstract Background Alzheimer’s disease is characterized by an abnormal increase of phosphorylated tau (pTau) species in the CSF. It has been suggested that emergence of different pTau forms may parallel disease progression. Therefore, targeting multiple specific pTau forms may allow for a deeper un...

Full description

Bibliographic Details
Main Authors: Johan Gobom, Andréa L. Benedet, Niklas Mattsson-Carlgren, Laia Montoliu-Gaya, Nina Schultz, Nicholas J. Ashton, Shorena Janelidze, Stijn Servaes, Mathias Sauer, Tharick A. Pascoal, Thomas K. Karikari, Juan Lantero-Rodriguez, Gunnar Brinkmalm, Henrik Zetterberg, Oskar Hansson, Pedro Rosa-Neto, Kaj Blennow
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Molecular Neurodegeneration
Subjects:
Tau
Phosphorylation
Alzheimer’s disease
LC–MS
Cerebrospinal fluid
Online Access:https://doi.org/10.1186/s13024-022-00586-0

Internet

https://doi.org/10.1186/s13024-022-00586-0

Similar Items